Abstract
The classic complement system consists of nine numbered components and two or three inhibitors. The first component comprises three subcomponents, Clq, Clr, and Cls, and it is the molecular interaction between Clq and aggregated IgG or IgM (as in an antigen-antibody complex) that initiates activation of the classic complement sequence (Fig. 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Abramson, N., Alper, C. A., Lachmann, P. J., Rosen, F. S., and Jandl, J. H., 1971, Deficiency of C3 inactivator in man, J. Immunol. 107: 19.
Agarwal, D. P., Benkmann, H.-G., and Goedde, H. W., 1974. Levels of serum ß,C/ PIA globulin (C3) and its polymorphism in leprosy patients and healthy controls from Ethiopia and Mali, Humangenetik 21: 355.
Agarwal, D. P., Neméthy, I., Benkmann, H.-B., and Goedde, H. W., 1973, Genetic polymorphism of C3: levels of total hemolytic complement activity and /31e-globulin in different phenotypes of C3 in a North German population, Hum. Hered. 23: 357.
Agnello, V., deBracco, M. M. E., and Kunkel, H. G.. 1972, Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus, J. Immunol. 108: 837.
Allen, F. H., Jr., 1974, Linkage of HL-A and GBG, Vox Sang. 27: 382.
Alper, C. A., 1970, Genetic polymorphism of human C3. in “Protides of the Biological Fluids,” Vol. 17 ( H. Peeters, ed.), pp. 295–300, Pergamon Press, Oxford.
Alper, C. A., and Jonhson, A. M., 1969, Immunofixation electrophoresis: a technique for the study of protein polymorphism, Vox Sang. 17: 445.
Alper, C. A., and Propp, R. P., 1967, An electrophoretic variant of human C’3 (Abstract), Clin. Res. 15: 291.
Alper, C. A., and Propp, R. P., 1968, Genetic polymorphism of the third component of human complement, J. Clin. Invest. 47: 2181.
Alper, C. A., and Rosen, F. S., 1967, Studies of the in vivo behavior of human C’3 in normal subjects and patients, J. Clin. Invest. 46: 2021.
Alper, C. A., and Rosen, F. S., 1971, Genetic aspects of the complement system, in “Advances in Immunology” (H. G. Kunkel and F. J. Dixon. eds.), pp. 251–290, Academic Press, New York.
Alper, C. A., and Rosen, F. S., 1971, Studies of a hypomorphic variant of human C3, J. Clin. Invest. 50: 324.
Alper, C. A., Boenisch, T., and Watson, L., 1972, Genetic polymorphism in human glycine-rich beta-glycoprotein, J. Exp. Med. 135: 68.
Alper, C. A., Goodkofsky, I., and Lepow, I. H.. 1973. The relationship of glycine-rich beta-glycoprotein to Factor B in the properdin system and to the cobra factor-binding protein of human serum, J. Exp. Med. 137: 424.
Alper, C. A., Robin, N. I., and Refetoff, S.. 1971, Genetic polymorphism in rhesus C3 and Gc globulin, J. Immunol. 107: 96.
Alper, C. A., Rosen, F. S., and Lachmann, P. J., 1972, Inactivator of the third component of complement as an inhibitor in the properdin pathway, Proc. Natl. Acad. Sci. U.S.A. 69: 2910.
Alper, C. A., Johnson, A. M., Birtch, A. G., and Moore, F. D., 1969, Human C’3: evidence for the liver as the primary site of synthesis, Science 163: 286.
Alper, C. A., Propp, R. P., Klemperer, M. R., and Rosen, F. S., 1969, Inherited deficiency of the third component of human complement (C’3). J. Clin. Invest. 48: 553.
Alper. C. A., Abramson, N., Johnston, R. B., Jr., Jandl, J. H., and Rosen, F. S., 1970, Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection, J. Clin. Invest. 49: 1975.
Alper, C. A., Abramson, N., Johnston, R. B., Jr., Jandl, J. H., and Rosen, F. S., 1970, Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3), N. Engl. J. Med. 282: 349.
Alper, C. A., Colten, H. R., Gear, J. S. S., Rabson, A. R., and Rosen, F. S., 1976, Homozygous human C3 deficiency: the role of C3 in antibody production, CT-induced vasopermeability and cobra venom-induced passive hemolysis, J. Clin. Invest. 57: 222.
Alper, C. A., Colten, H. R., Rosen, F. S., Rabson, A. R., Macnab, G. M., and Gear, J. S. S., 1972, Homozygous deficiency of C3 in a patient with repeated infections, Lancet 11:1179.
Alper, C. A., Azen, E. A., Geserick, G., Goedde, H. W., Rittner, Ch., Teisberg, P., and Wieme, R., 1973, Statement on the polymorphism of the third component of complement in man (C3), Vox Sang. 25: 18.
Arroyave, C. M., Personal communication.
Arroyave, C. M., Levy, R. M., and Johnson, J. S., 1975, Genetic deficiency of the fourth component of complement in Wistar rats (Abstract), Federation Proc. 33: 795.
Arvilommi, H. A., 1972, Studies on serum Pi-and C3-polymorphism in Finland, Acta Pathol. Microhiol. Scand. Suppl.:234.
Arvilommi, H., 1974, Capacity of complement C3 phenotypes to bind on to mononuclear cells in man, Nature 251: 740.
Arvilommi, H., Berg, K., and Eriksson, A. W., 1973, C3 types and their inheritance in Finnish Lapps, Maris (Cheremisses) and Greenland Eskimos, Humangenetik 18: 253.
Austen, K. F., and Sheffer, A. L., 1965, Detection of hereditary angioneurotic edema by demonstration of a reduction in the second component of human complement, N. Engl. J. Med. 272: 649.
Azen, E. A., and Cooper, N. R., 1971, Characterization of C4 in acid—urea starch gel system (Abstract), Clin. Res. 19: 437.
Azen, E. A., and Smithies, O., 1968, Genetic polymorphism of C’3 (ß,c-globulin) in human serum, Science 162: 905.
Azen, E. A., Smithies, O., and Hiller, O., 1969, High-voltage starch-gel electrophoresis in the study of post-albumin proteins and C’3 (ß„-globulin) polymorphism, Biochem. Genet. 3: 215.
Bach, S., Ruddy, S., and Austen, K. F., 1971, Electrophoretic polymorphism of the fourth component of human complement (C4) in paired maternal and foetal plasmas, Immunology 21: 869.
Ballow, M., Shira, J. E., Harden, L., Yang, S. Y., and Day, N. K., 1975, Complete absence of the third component of complement in man, J. Clin. Invest. 56: 703.
Beckman, L., Brönnestam, R., Cedergren, B., and Uden, S., 1974, HL-A antigens, blood groups, serum groups, and red cell enzyme types in psoriasis, Hum. Hered. 24: 496.
Berg, K., and Eriksson, A. W., 1973, Genetic marker systems in Arctic populations. VI. Polymorphism of C3 in Icelanders, Hum. Hered. 23: 247.
Berg, K., Arvilommi, H., and Eriksson, A. W., 1972, Genetic marker systems in Arctic populations, Hum. Hered. 22: 481.
Berg, K., Noer, G., Heiberg, A., 1970, Studies on the genetic polymorphism of the C’3 of human serum, Clin. Genet. 1: 177.
Biro, C. E., 1966, The role of C6 in some types of hypersensitivity, Immunology 10: 563.
Biro, C. E., and Ortega, M. L., 1966, Algunas características del sexto componente del complemento, Arch. Inst. Cardiol. Mex. 36: 166.
Boyer, J. T., Gall, E. P., Norman, M. E., Nilsson, U. R., and Zimmerman, T. S., 1975, Hereditary deficiency of the seventh component of complement, J. Clin. Invest. 56: 905.
Brönnestam, R., 1973, Studies of the C3 polymorphism. Relationship between phenotype and quantitative immunochemical measurements, Hum. Hered. 23: 128.
Brönnestam, R., 1973, Studies of the C3 polymorphism. Relationship between C3 phenotypes and rheumatoid arthritis, Hum. Hered. 23: 206.
Brönnestam, R., 1973, Studies of the C3 polymorphism. Distribution of C3 phenotypes in different areas of Sweden, Hum. Hered. 23: 361.
Brönnestam, R., and Cedergren, B., 1972, Studies of the C3 polymorphism. Relationship between C3 phenotypes and antibody titres, Hum. Hered. 23: 214.
Brönnestam, R., Beckman, L., and Cedergren, B., 1971, Genetic polymorphism of the complement component C3 in Swedish Lapps, Hum. Hered. 21: 267.
Caren, L. D., and Rosenberg, L. T., 1965, Complement in skin grafting in mice, Immunology 9: 359.
Caren, L. D., and Rosenberg, L. T., 1966, The role of complement in resistance to endogenous and exogenous infection with a common mouse pathogen, Corynebacterium kutscheri, J. Exp. Med. 124: 689.
Carpenter, C. B., Ruddy, S., Shehadeh, I. H., Müller-Eberhard, H. J., Merrill, J. P., and Austen, K. F., 1969, Complement metabolism in man: hypermetabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary angioedema, J. Clin. Invest. 48: 1495.
Champion, R. H., and Lachmann, P. J., 1969, Hereditary angioedema treated with eaminocaproic acid, Br. J. Dermatol. 81: 763.
Cinader, B., and Dubiski, S., 1963, An alpha-globulin allotype in the mouse (MuBI), Nature 200: 781.
Cinader, B., Dubiski, S., and Wardlaw, A. C., 1964, Distribution, inheritance, and properties of an antigen, MuBI, and its relation to hemolytic complement, J. Exp. Med. 120: 897.
Cinader, B., Jeejeebhoy, H. F., Koh, S. W., and Rabbat, A. G., 1971, Immunosuppressive and graft-rejecting antibodies in heterologous anti-lymphocytic serum, J. Exp. Med. 133: 81.
Colten, H. R., 1972, Ontogeny of the human complement system: in vitro biosynthesis of individual complement components by fetal tissue, J. Clin. Invest. 51: 725.
Colten, H. R., 1972, In vitro synthesis of a regulator of mammalian gene expression, Proc. Natl. Acad. Sci. U.S.A. 69: 2233.
Colten, H. R., and Alper. C. A., 1972, Hemolytic efficiencies of genetic variants of human C3, J. Immunol. 108: 1184.
Colten, H. R., and Frank, M. M., 1972, Biosynthesis of the second and fourth components of complement in vitro by tissues isolated from guinea pigs with genetically determined C4 deficiency, Immunology 22: 991.
Cotten, H. R., and Parkman, R., 1972. Biosynthesis of the fourth component of complement (C4) by C4-deficient guinea pig—HeLa cell hybrids, Science 176: 1029.
Colten, H. R., Borsos, T., and Rapp, H. J., 1970, Isoelectric focusing of human and guinea pig C2: polymorphism of guinea pig C2, Immunology 18: 467.
Cooper, N. R., ten Bensel, R., and Kohler, P. F., 1968, Studies of an additional kindred with hereditary deficiency of the second component of human complement (C2) and description of a new method for the quantitation of C2, J. Immunol. 101: 1176.
Crisler, C., and Frank, M. M., 1965, Skin graft rejection and the Arthus reaction in mice deficient in the third component (C’3) of complement (Abstract), Federation Proc. 24: 447.
Davis, J. S., IV, Personal communication.
Day, N. K., Geiger, H., McLean, R., Michael, A., and Good. R. A., 1973, C2 deficiency: development of lupus erythematosus, J. Clin. Invest. 52: 1601.
Day, N. K., Geiger, H., Stroud, R., deBracco, M., Mancado, B., Windhorst, D., and Good, R. A., 1972, C 1 deficiency: an inborn error associated with cutaneous and renal disease, J. Clin. Invest. 51: 1102.
Day, N. K., L’Esperance, P., Good, R. A., Michael, A. F., Hansen. J. A., Dupont, B., and Jersild, C., 1975, Hereditary C2 deficiency: genetic studies and association with the HL-A system, J. Exp. Med. 141: 1464.
DeBracco, M. M. E., Windhorst, D., Stroud, R. M., and Moncada, B., 1974, The autosomal recessive mode of inheritance of C1r deficiency in a large Puerto Rican family, Clin. Exp. Immunol. 16: 183.
Démant, P., Capkokd, J., Hinzovd, E., and Vorâcovd, B., 1973. The role of the histocompatibility-2-linked Ss—Slp region in the control of mouse complement, Proc. Natl. Acad. Sci. U.S.A. 70: 863.
Dissing, J., and Sorensen, H., 1971, Studies on C’3 polymorphism in Denmark, Hum. Hered. 21: 272.
Dissing, J., Lund, J., and Sorensen, H., 1972, C3 polymorphism in a group of old arteriosclerotic patients, Hum. Hered. 22: 466.
Donaldson, V. H., 1968, Mechanisms of activation of C’1 esterase in hereditary angioneurotic edema plasma in vitro. The role of Hageman factor, a clot-promoting agent, J. Exp. Med. 127: 411.
Donaldson, V. H., and Evans, R. R., 1963, A biochemical abnormality in hereditary angioneurotic edema: absence of a serum inhibitor of C1-esterase, Am. J. Med. 35: 37.
Donaldson, V. H., and Rosen, F. S., 1964, Action of complement in hereditary angioneurotic edema: the role of C’ 1 esterase, J. Clin. Invest. 43: 2204.
Donaldson, V. H., and Rosen, F. S., 1966, Hereditary angioneurotic edema. A clinical survey, Pediatrics 37: 1017.
Donaldson, V., and Stroud, R. M., 1974, Genetic defects of complement, in “Progress in Immunology II,” Vol. 1 (L. Brent and J. Holborow, eds.), p. 290, North-Holland Publishing Company, Amsterdam.
Donaldson, V. H., Ratnoff, O. D., Dias da Silva, W., and Rosen, F. S., 1969, Permeability-increasing activity in hereditary angioneurotic edema: mechanism of formation and partial characterization, J. Clin. Invest. 48: 642.
Dubiski, S., and Cinader, B., 1966, Gene dosage effect of serum concentration of a complement component, MuBI, Proc. Soc. Exp. Biol. Med. 122: 775.
Ecker, E. E., 1921, Quantitative relations between amboceptor and the serum of complement deficient guinea pigs, J. Infect. Dis. 29: 611.
Einstein, L. P., Alper, C. A., Bloch, K. J., Herrin, J. T., Rosen, F. S., David, J. R., and Colten, H. R., 1975, Biosynthetic defect in monocytes from human beings with genetic deficiency of the second component of complement, N. Engl. J. Med. 292: 1169.
Ellman, L., Green, I., and Frank, M., 1970, Genetically controlled total deficiency of the fourth component of complement in the guinea pig, Science 170: 74.
Ellman, L., Green, I., Judge, F., and Frank, M. M., 1972, In vivo studies in C4-deficient guinea pigs, J. Exp. Med. 134: 162.
Erickson, R. P., Tachibana, D. K., Herzenberg, L. A., and Rosenberg, L. T., 1964, A single gene controlling hemolytic complement and a serum antigen in the mouse, J. Immunol. 92: 611.
Farhud, D. D., and Walter, H., 1973, Verwendung des C3 (/31 -globulin)—Polymorphismus bei der Vaterschaftsbegutachtung, Z. Rechtsmed. 72: 225.
Farhud, D. D., and Walter, H., 1973, Polymorphism of C’3 in German, Bulgarian, Iranian and Angola population, Humangenetik 17:161.
Farhud, D. D., Ananthakrishnan, R., and Walter, H., 1972, Association between C’3 phenotypes and various diseases, Humangenetik 17: 57.
Ferreira, A., and Nussenzweig, V., 1975, Genetic control of complement (C3) levels and of the development of the lymphoid system (Abstract), Federation Proc. 34: 979.
Forbes, C. D., Pensky, J., and Ratnoff, O. D., 1970, Inhibition of activated Hageman factor and activated thromboplastin antecedent by purified serum CI inactivator, J. Lab. Clin. Med. 76: 809.
Frank, M. M., May, J. E., and Kane, M. A., 1973, Contributions of the classical and alternate pathways to the biological effects of endotoxin, J. Infect. Dis. 128: 5176.
Frank, M. M., May, J., Gaither, T., and Ellman, L., 1971, In vitro studies of complement function in sera of C4-deficient guinea pigs, J. Exp. Med. 134: 176.
Frank, M. M., Sergent, J. S., Kane, M. A., and Ailing, D. W., 1972, Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study, N. Engl. J. Med. 286: 808.
Fraser, G. R., Volkers, W. S., Bernini, L. F., De Greve, W. B., van Loghem, E., Meera Khan, P., Nijenhuis, L. E., Veltkamp, J. J., Vogel, G. P., and Went, L. N., 1974, A search for associations between genetical polymorphic systems and physical, biochemical and hematological variables, Hum. Hered. 24: 424.
Fu, S. M., Kunkel, H. G., Brusman, H. P., Allen, F. H., Jr., and Fortino, M., 1974, Evidence for linkage between HL-A histocompatibility genes and those involved in synthesis of the second component of complement, J. Exp. Med. 140: 1108.
Gedde-Dahl, T., Jr., Teisberg, P., and Thorsby, E., 1974, C3 polymorphism: genetic linkage relations, Clin. Genet. 6: 66.
Gelfand, E. W., Clarkson, J. D., and Minta, J. O., 1975, Selective deficiency of the second component of complement in a patient with anaphylactoid purpura, Clin. Immunol. Immunopathol. 4: 269.
Geserick, G., Rose, M., and Schnitzler, St., 1970, Untersuchungen zur Identität des polymorphen Serumproteins Pt, Z. Immunitaetsforsch. Allerg. klin. Immunol. 140: 54.
Geserick, G., Marth, H., Schnitzler, St., Gögochia, S. D., Mirvis, A. B., and Annenkow, H. A., 1971, Pt-Typenverteilung bei einem Bevölkerungsisolat im abchasischen Swanetien (Grusinien), Acta Biol. Med. Ger. 26: 411.
Gigli, I., Ruddy, S., and Austen, K. F., 1968, The stoichiometric measurement of the serum inhibitor of the first component of complement by the inhibition of immune hemolysis, J. Immunol. 100: 1154.
Gigli, I., Mason, J. W., Colman, R. W., and Austen, K. F., 1970, Interaction of plasma kallikrein with the Cl inhibitor, J. Immunol. 104: 574.
Glahs, G., 1974, Der Polymorphismus der Komplement-Komponente C’3 in Österreich, Med. Lab. (Stuttg.) 27: 53.
Glass, D., Gibson, D. J., Carpenter, C. B., and Schur, P. H., 1976, Hereditary C2 deficiency: HLA gene complex associations with recombinant events (Abstract), J. Immunol. 116: 1734.
Glynn, A. A., and Medhurst, F. A., 1967, Possible extracellular and intracellular bactericidal actions of mouse complement, Nature 213: 608.
Goedde, H. W., Benkmann, H.-G., Agarwal, D. P., and Hirth, L., 1972, Further investigations on inherited polymorphism of the third component of complement (ß, C/ß, A-globulin), Hum. Hered. 22: 488.
Goedde, H. W., Hirth, L., Benkmann, H.-G., Pellicer, A., Pellicer, T., Stahn, M., Suigh, S., 1973, Population genetic studies and serum protein polymorphisms in four Spanish populations, Hum. Hered. 23: 135.
Goldman, M. B., and Goldman, J. N., 1975, Relationship of levels of early components of complement to the H-2 complex of mice (Abstract), Federation Proc. 34: 979.
Granerus, G., Hallberg, L., Laurel], A. B., and Wetterquist, H., 1967, Studies on histamine metabolism and the complement system in hereditary angioneurotic edema, Acta Med. Scand. 182: 11.
Grace, H. J., and Vos, G. H., Personal communication.
Greitz, H., Reutter, W., and Schmutzler, W., 1964, Release of histamine from rabbit blood cells by an anaphylatoxin-like substance formed in normal and C’3 defect rabbit plasma, Nature 202: 1346.
Hansen, T. H., Krasteff, T. N., and Shreffler, D. C., 1974, Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype SIp, Biochem. Genet. 12: 281.
Hansen, T. H., Shin, H. S., and Shreffler, D. C., 1975, Evidence for the involvement of the Ss protein of the mouse in the hemolytic complement system, J. Exp Med. 141: 1216.
Harpel, P. C., and Cooper, N. R., 1975, Studies on human plasma CT inactivatorenzyme interactions. I. Mechanisms of interaction with Cls, plasmin, and trypsin, J. Clin. Invest. 55: 593.
Harpel, P. C., Hugli, T. E., and Cooper, N. R., 1975, Studies on human plasma CT inactivator—enzyme interactions. II. Structural features of an abnormal Cl inactivator from a kindred with hereditary angioneurotic edema, J. Clin. Invest. 55: 605.
Hauptmann, G., Grosshans, E., Heid, E., Mayer, S., and Basset, A., 1974, Lupus érythémateux aigu avec déficit complet de la fraction C4 du complément, Nouv. Presse Med. 3: 881.
Heusinkveld, R. S., Leddy, J. P., Klemperer, M. R., and Breckenridge, R. T., 1974, Hereditary deficiency of the sixth component of complement in man, J. Clin. Invest. 53: 554.
Hinzovd, E., Démant, P., and Ivânyi, P., 1972, Genetic control of haemolytic complement in mice: association with H-2, Folio Biol. (Prague) 18: 237.
Hobart, M. J., Lachmann, P. J., and Alper, C. A., 1975, Polymorphism of human C6, in “Protides of the Biological Fluids,” Vol. 22 (H. Peeters, ed.), pp. 575–580, Pergamon Press, New York.
Howie, J. B., and Helyer, B. J., 1965, Autoimmune disease in mice, Ann. N.Y. Acad. Sci. 124: 167.
Hrdy, D. B., Barnicot, N. A., and Alper, C. A., 1975, Protein polymorphism in the Hanuman langur (Presbytis entellus), Folio Primatol. 24: 173.
Hyde, R. R., 1923, Complement-deficient guinea-pig serum, J. Immunol. 8: 267.
Hyde, R. R., 1932, The complement deficient guinea pig: a study of an inheritable factor in immunity, Am. J. Hvg. 15: 824.
Johnson, A. M., Alper, C. A., Rosen, F. S., and Craig, J. M., 1971, CT inhibitor: evidence for decreased hepatic synthesis in hereditary angioneurotic edema, Science 173: 553.
Johnson, K. J., and Ward, P. A., 1971, Protective function of C6 in rabbits treated with bacterial endotoxin, J. Immunol. 106: 1125.
Johnston, R. B., Jr., Klemperer, M. R., Alper, C. A., and Rosen, F. S., 1969, The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors, J. Exp. Med. 129: 1275.
Kane, M. A., May, J. E., and Frank, M. M., 1973, Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation, J. Clin. Invest. 52: 370.
Klemperer, M. R., 1969, Hereditary deficiency of the second component of complement in man: an immunochemical study, J. Immunol. 102: 168.
Klemperer, M. R., Austen, K. F., and Rosen, F. S., 1967, Hereditary deficiency of the second component of complement (C’2) in man, J. Immunol. 98: 72.
Klemperer, M. R., Donaldson, V. H., and Rosen, F. S., 1968, Effect of C’ 1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema, J. Clin. Invest. 47: 604.
Klemperer, M. R., Woodworth, H. C., Rosen, F. S., and Austen, K. F., 1966, Hereditary deficiency of the second component of complement in man, J. Cin. Invest. 45: 880.
Kohler, P. F., Percy, J., Campion, W. M., and Smyth, C. J., 1974, Hereditary angioedema and “familial” lupus erythematosus in identical twin boys, Am. J. Med. 56: 406.
Kühnl, P., and Spielmann, W., 1972, Untersuchungen zum C’3-Polymorphismus (Ow-globulin), Humangenetik 15: 7.
Lachmann, P. J., 1970, C6-deficiency in rabbits, in “Protides of the Biological Fluids,” Vol. 17 (H. Peeters, ed.), pp. 301–309, Pergamon Press, Oxford.
Landerman, N. S., 1962, Hereditary angioneurotic edema. I. A case report and review of the literature, J. Allergy 33: 316.
Landerman, N. S., Webster, M. E., Becker, E. L., and Ratcliffe, H. E., 1962, Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein, J. Allergy 33: 330.
Laurell, A.-B., and Martensson, U., 1971, CT inactivator protein complexed with albumin in plasma from a patient with angioneurotic edema, Eur. J. Immunol. 1: 146.
Laurell, A. B., Lindegren, J., Malmros, I., and Martensson. H., 1969, Enzymatic and immunochemical estimation of C 1 esterase inhibitor in sera from patients of hereditary angioneurotic edema, Scand. J. Clin. Invest. 24: 221.
Leddy, J. P., Griggs, R. C., Klemperer, M. R., and Frank, M. M., 1975, Hereditary complement (C2) deficiency with dermatomyositis, Am. J. Med. 58: 83.
Leddy, J. P., Frank, M. M., Gaither, T., Baum, J., and Klemperer, M. R., 1974, Hereditary deficiency of the sixth component of complement in man. I. Immunochemical, biologic, and family studies, J. Clin. Invest. 53: 544.
Levy, N. L., and Ladda, R. L., 1971, Restoration of hemolytic complement activity in CS-deficient mice by gene complementation in hybrid cells, Nature (London) New Biol. 229: 51.
Levy, N. L., Synderman, R., Ladda, R. L., and Lieberman, R., 1973, Cytogenetic engineering in vivo: restoration of biologic complement activity to C5-deficient mice by intravenous inoculation of hybrid cells, Proc. Natl. Acad. Sci. U.S.A. 70: 3125.
Lindberg, L. H., and Rosenberg, L. T., 1968, Nephrotoxic serum nephritis in mice with a genetic deficiency in complement, J. Immunol. 100: 34.
Lundh, B., Laurell, A. B., Wetterqvist, H., White, T., and Granerus, G., 1968, Case report: a case of hereditary angioneurotic oedema successfully treated with epsilonaminocaproic acid. Studies on C’ 1 esterase inhibitor, C’ 1 activation, plasminogen level and histamine metabolism, Clin. Exp. Immunol. 3: 733.
Mauff, G., Potrafki, B. G., Freis, H., and Pulverer, G., 1974, Vergleichende Untersuchungen zum Polymorphismus des Posttransferrins (Pt) and der dritten Komponente des Human Komplements (C3), Humangenetik 21: 75.
May, J. E., and Frank, M. M., 1972, Complement-mediated tissue damage: contribution of the classical and alternate complement pathways in the Forssman reaction, J. Immunol. 108: 1517.
May, J. E., Green, I., and Frank, M. M., 1972, The alternate complement pathway in cell damage: antibody-mediated cytolysis of erythrocytes and nucleated cells, J. Immunol. 109: 595.
May, J. E., Kane, M. A., and Frank, M. M., 1972, Host defense against bacterial endotoxemia: contribution of the early and late components of complement to detoxification, J. Immunol. 109: 893.
May, J. E., Kane, M. A., and Frank, M. M., 1972, Immune adherence by the alternate complement pathway, Proc. Soc. Exp. Biol. Med. 141: 287.
Meo, T., Krasteff, T., and Shreffler, D. C., 1975, Immunochemical characterization of murine H-2 controlled Ss (serum substance) protein through the identification of its human homologue as the fourth component of complement, Proc. Natl. Acad. Sci. U.S.A. 72: 4536.
Miller, G. W., and Nussenzweig, V., 1975, A new complement function: solubilization of antigen—antibody aggregates, Proc. Natl. Acad. Sci. U.S.A. 72: 418.
Moncada, B., Day, N. K., Good, R. A., and Windhorst, D. B., 1972, Lupuserythematosus-like syndrome with a familial defect of complement, N. Engl. J. Med. 286: 689.
Moore, H. D., 1919, Complementary and opsonic functions in their relation to immunity. A study of the serum of guinea-pigs naturally deficient in complement, J. Immunol. 4: 425.
Müller-Eberhard, H. J., 1975, Complement, in “Annual Review of Biochemistry,” Vol. 44 (E. E. Snell, P. D. Boyer, A. Meister, and C. C. Richardson, eds.), pp. 697–724, Annual Reviews Inc., California.
Nelson, R. A., and Biro, C. E., 1968, Complement components of a hemolytically deficient strain of rabbits, Immunology 14: 527.
Ochs, H. D., Jackson, C. G., and Wedgwood, R. J., Personal communication.
Okada, N., and Rosenberg, L. T., 1964, T2 phage neutralizing activity of mouse serum (Abstract), Bacteriol. Proc. 64: 141.
Oster, W., 1888, Hereditary angioneurotic edema, Arn. J. Doled. Sci. 95: 362.
Osterlund, C. K., Espinoza, L., Parker, L. P., and Schur, P. H., 1975, Inherited C2 deficiency and systemic lupus erythematosus: studies on a family, Ann. Intern. Med. 82: 323.
Passmore, H. C., and Shreffler, D. C., 1970, A sex-limited serum protein variant in the mouse: inheritance and association with the H-2 region, Biochem. Genet. 4: 351.
Pensky, J., and Schwick, H. G., 1969, Human serum inhibitor of Cl esterase: identity with alpha 2-neuraminoglycoprotein, Science 163: 698.
Pensky, J., Levy, L. R., and Lepow, I. H., 1961, Partial purification of a serum inhibitor of C’ 1 esterase, J. Biol. Chem. 236: 1674.
Peters, D. K., 1974, Alternative pathways of complement activation, in “Progress in Immunology II,” Vol. I (L. Brent and J. Holborow, eds.), p. 297, North-Holland Publishing Company, Amsterdam.
Petersen, B. H., Graham, J. A., and Boroks, G. F., 1975, Human deficiency of the 8th component of complement (Abstract), Clin. Res. 23: 294A.
Phillips, M. E., Rother, U. A., Rother, K. O., and Thorbecke, G. J., 1969, Studies on the serum proteins of chimeras. III. Detection of donor type C’5 in allogeneic and congenic post-irradiation chimeras, Immunology 17: 315.
Pickering, R. J., Kelly, J. R., Good, R. A., and Gewurz, H., 1969, Replacement therapy in hereditary angioedema. Successful treatment of two patients with fresh frozen plasma, Lancet 1: 326.
Pillemer, L., Blum, L., Lepow, I. H., Ross, O. A., Todd. E. W., and Wardlaw, A. C., 1954, The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune pheomena, Science 120: 279.
Polley, M. J., 1968, Inherited C’2 deficiency in man: lack of immunochemically detectable C’2 protein in serums from deficient individuals, Science 161: 1149.
Prokop, O., Rose, H., and Geserick, G., 1970, Die Anwendung des Posttransferrin Polymorphismus (Pt) in der Vaterschaftsbegutachtung, Dtsch. Gesundheitwes. 25: 1910.
Propp, R. P., and Alper, C. A., 1968, C’3 synthesis in the human fetus and lack of transplacental passage, Science 162: 672.
Quincke, H., 1882, Über akutes umschriebenes Hautödem, Monatsh. Prak. Dermat. 1: 129.
Ratnoff, O. D., Pensky, J., Ogston, D., and Naff, G. B., 1969, The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C’ Ir subcomponent of the first component of complement by serum C’ 1 esterase inhibitor, J. Exp. Med. 129: 315.
Rittner, Ch., and Hauptmann, G., Personal communication.
Rittner, Ch., and Rittner, B., 1973, Description of three hitherto unknown C3 variants: F 0.6, F 0.7 and S 2.4 (old nomenclature), included in the workshop (Abstract), Vox Sang. 25: 17.
Rittner, Ch., Grosse-Wilde, H., Rittner, B., Netzel, B., Scholz, S., Lorenz, H., and Albert, E. D., 1975, Linkage group HL-A-MLC-BF (Properdin Factor B). The site of the Bf locus at the immunogenetic linkage group on chromosome 6, Humangenetik 27: 173.
Root, R. K., Ellman, L., and Frank, M. M., 1972, Bactericidal and opsonic properties of C4-deficient guinea pig serum, J. Immunol. 109: 477.
Rose, M., and Geserick, G., 1969, Ein neuer Serumproteinpolymorphismus: Pt. Erste Hinweise für eine genetische Steuerung, Acta Biol. Med. Ger. 23: 351.
Rosen, F. S., Charache, P., Donaldson, V., and Pensky, J., 1965, Hereditary angioneurotic edema: two genetic variants, Science 148: 957.
Rosen, F. S., Alper, C. A., Pensky, J., Klemperer, M. R.. and Donaldson, V. H., 1971, Genetically determined heterogeneity of the CI esterase inhibitor in patients with hereditary angioneurotic edema, J. Clin. Invest. 50: 2143.
Rosenfeld, S. I., and Leddy, J. P., 1974, Hereditary deficiency of fifth component of complement (C5) in man (Abstract), J. Clin. Invest. 53: 67a.
Rosenfeld, S. I., Ruddy, S., and Austen, K. F., 1969, Structural polymorphism of the fourth component of human complement, J. Clin. Invest. 48: 2283.
Rother, K., and Rother, U., 1965, Studies on complement defective rabbits. IV. Blood clearance of intravenously injected S. typhi by the reticuloendothelial system, Proc. Soc. Exp. Biol. Med. 119: 1055.
Rother, K., Rother, U., and Schindera, F., 1964, Passive Arthus-Reaktion bei Komplement-Defekt Kaninchen, Z. Immunitaetsforsch. exp. Ther. 126: 473.
Rother, K., Rother, U., Müller-Eberhard, H. J., and Nilsson, U. R., 1966, Deficiency of C6 in rabbits with an inherited complement defect, J. Exp. Med. 124: 773.
Rother, K., Rother, U., Vassali, P., and McCluskey, R. T., 1967, Nephrotoxic serum nephritis in C’6-deficient rabbits. I. Study of the second phase of the disease, J. Immunol. 98: 965.
Rother, U., and Rother, K., 1961, Ober einen eingeborenen Komplement-Defekt bei Kaninchen, Z. Immunitaetsforsch. exp. Ther. 121: 224.
Ruddy, S., and Austen, K. F., 1967, A stoichiometric assay for the fourth component of complement in whole human serum using EAC’laó’ and functionally pure human second component, J. Immunol. 99: 1162.
Ruddy, S., Klemperer, M. R., Rosen, F. S., Austen, K. F., and Kumate, J., 1970, Hereditary deficiency of the second component of complement (C2) in man, Immunology 18: 943.
Schreiber, A. D., and Frank, M. M., 1972, Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites, J. Clin. Invest. 51: 575.
Schultze, H. E., Heide, K., and Haupt, H., 1962, Über ein bisher unbekanntes saures alpha 2 Glykoprotein, Naturwissenschaften 49: 133.
Seth, S., and Berndt, H., 1974, Genetic polymorphism of the human complement component C’3 among North Germans, Humangenetik 21: 59.
Sheffer, A. L., Austen, K. F., and Rosen, F. S., 1972, Tranexamic acid therapy in hereditary angioneurotic edema, N. Engl. J. Med. 287: 452.
Sheffer, A. L., Craig, J. M., Willms-Kretschmer, K., Austen, K. F., and Rosen, F. S., 1971, Histopathological and ultrastructural observations on tissue from patients with hereditary angioneurotic edema, J. Allergy 47: 292.
Shevach, E., Green, I., and Frank, M. M., 1976, Linkage of C4 deficiency to the major histocompatibility locus in the guinea pig (Abstract), J. Immunol. 116: 1750.
Shin, H. S., Smith, M. R., and Wood, W. B., Jr., 1969, Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5, J. Exp. Med. 130: 1229.
Shokeir, M. H., 1973, The genetics of hereditary angioedema: a hypothesis, Clin. Genet. 4: 494.
Shreffler, D. C., 1965, The Ss system of the mouse—A quantitative serum protein difference genetically controlled by the H-2 region, in “Isoantigens and Cell Interactions” (J. Palm, ed.), pp. 11–19, Wistar Institute Press, Philadelphia.
Shreffler, D. C., and Owen, R. D., 1963, A serologically detected variant in mouse serum: inheritance and association with the Histocompatibility-2 locus, Genetics 48: 9.
Spaulding, W. B., 1960, Methyltestosterone therapy for hereditary episodic edema, Arch. Intern. Med. 53: 739.
Stiffel, C., Biozzi, G., Monton, D., Bouthillier, Y., and Decreusefond, C., 1964, Studies on phagocytosis of bacteria by the reticulo-endothelial system in a strain of mice lacking hemolytic complement, J. Immunol. 93: 246.
Stossel, T. P., Alper, C. A., and Rosen, F. S., 1973, Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharide, J. Exp. Med. 137: 690.
Stossel, T. P., Alper, C. A., and Rosen, F. S., 1973, Opsonic activity in the newborn: role of properdin, Pediatrics 134: 173.
Stratton, F., Personal communication.
Sussman, M., Jones, J. S., Almeida, J. D., and Lachmann, P. J., 1973, Deficiency of second component of complement associated with anaphylactoid purpura and presence of mycoplasma in the serum, Clin. Exp. Immunol. 14: 531.
Tachibana, D. K., Ulrich, M., and Rosenberg, L. T., 1963. The inheritance of hemolytic complement activity in CF-1 mice, J. Immunol. 91: 230.
Teisberg, P., 1970, New variants in the C3 system, Hum. Hered. 20: 631.
Teisberg, P., 1971, The distribution of C3 types in Norway, Hum. Hered. 21: 154.
Teisberg, P., 1971, C3 types of Norwegian Lapps, Hum. Hered. 21: 162.
Teisberg, P., 1971, Genetics of the C3 system: family, mother/child, and association studies, Hum. Hered. 21: 458.
Teisberg, P., Olaisen, B., Gedde-Dahl, T., Jr., and Thorsby, E., 1975, On the localization of the Gb locus within the MHS region of chromosome no. 6, Tissue Antigens 5: 257.
Tobelem, G., Wautier, J. L., and Peltier, A. P., 1974, C2 deficiency, platelet aggregation reduction, and Lobstein’s disease in the same family, Biomed. Express (Paris) 21: 190.
Unanue, E. R., Mardiney, M. R., and Dixon, F. J., 1967, Nephrotoxic serum nephritis in complement intact and deficient mice, J. Immnol. 98: 609.
Volk, H., Mauersberger, D., Rother, K., and Rother, U., 1964, Prolonged survival of skin homografts in rabbits defective in the third component of complement, Ann. N. Y. Acad. Sci. 120: 26.
Ward, P. A., Cochrane, C. G., and Müller-Eberhard, H. J., 1965, The role of serum complement in chemotaxis of leukocytes in vitro, J. Exp. Med. 122: 327.
Weitkamp, L. R., Johnston, E., and Guttormsen, S. A., 1974, Probable genetic linkage between loci for Lewis blood-group and complement-C3, Cytogenet. Cell Genet. 13: 183.
Wellek, B., and Opferkuch, W., 1975, A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of a C7-inactivating principle, Clin. Exp. Immunol. 19: 223.
Willms, K., Rosen, F. S., and Donaldson, V. H.. 1975, Observations on the ultrastructure of lesions induced in human and guinea pig skin by esterase and polypeptide from hereditary angioneurotic edema (HANE) plasma, Clin. Immunol. Immunopathol. 4: 174.
Wolski, K. P., Schmid, F. R., and Mittal, K. L., 1975, Genetic linkage between HL-A system and a deficit of the second component (C2) of complement, Science 188: 1020.
Yang, S. Y., Jensen, R., Folke, L., Good, R. A.. and Day, N. K., 1975, Complement deficiency in hamsters (Abstract), Federation Proc. 33: 795.
Ziegler, J. B., Alper, C. A., and Balner, H., 1975, Properdin factor B and histocompatibility loci linked in the rhesus monkey, Nature 254: 609.
Ziegler, J. B., Watson, L., and Alper, C. A., 1975, Genetic polymorphism of properdin Factor B in the rhesus: evidence for single subunit structure in primates, J. Immunol. 114: 1649.
Ziegler, J. B., Alper, C. A.. Rosen, F. S., Lachmann, P. J., and Sherington, L., 1975, Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiency, J. Clin. Invest. 55: 668.
Ziegler, J. B., Rosen, F. S., Alper. C. A., Grupe, W., and Lepow, I. H., 1975. Metabolism of properdin in normal subjects and patients with renal disease, J. Clin. Invest. 56: 761.
Zimmerman, T. S., Arroyave, C. M., and Müller-Eberhard, H. J., 1971, A blood coagulation abnormality in rabbits deficient in the sixth component of complement (C6) and its correction by purified C6, J. Exp. Med. 134: 1591.
Alper, C. A., 1976, Inherited structural polymorphism in human C2. Evidence for genetic linkage between C2 and Bf J. Exp. Med., in press.
Blum, L., Lee, K., Lee, S. L., Barone, R., and Wallace, S. L., 1976. Hereditary Cls deficiency (Abstract), Federation Proc. 35: 655.
Curman, B., Ostberg, L., Sandberg, L., Malmheden-Eriksson, I., Stalenheim, G., Rask, L., and Peterson, P. A., 1975, H-2 linked Ss protein is C4 component of complement, Nature 258: 243.
Day, N. K., Personal communication.
Day, N. K., Rubinstein, P., de Bracco, M., Moncada, B., Good, R. A., Hansen, J., Dupont, B., and Jersild, C., 1976, Hereditary Clr deficiency: lack of linkage to the HL-A region in two families (Abstract), J. Immunol., 116: 1731.
Fu, S. M., Stern, R., Kunkel, H. G., Dupont, B., Hansen, J. A., Day, N. K., Good, R. A., Jersild, C., and Fotino, M., 1975, Mixed lymphocyte culture determinants and C2 deficiency in four families, J. Exp. Med. 142: 495.
Gelfand, J. A., Sherins, R. J., Ailing, D. W., and Frank, M. M.. 1976, Effective prophylaxis of hereditary angioedema by an impeded androgen, Danazol (Abstract), Clin. Res. 24: 446A.
Grace, H. J., Brereton-Stiles, G. G., Vos, G. H., and Schonland, M., 1976, A family with partial and total deficiency of complement C3, S. Afr. Med. J. 50: 139.
Hauptmann, G., Sasportes, M., Tongio, M. M., Mayer, S., and Dausset, J., 1976, The localization of the Bf locus within the MHS region on chromosome no. 6, Tissue Antigens 7: 52.
Hobart, M. J., and Lachmann, P. J., Allotypes of complement components in man, Transplant. Rev., in press.
Jackson, C. G., Ochs, H. D., and Wedgwood, R. J., 1976, The interactions of the alternate and classical pathways of complement (C) in C deficiencies (Abstract), Federation Proc. 35: 655.
Lachmann, P. J., Grennan, D., Martin, A., and Demant, P., 1975. Identification of Ss protein as murine C4, Nature 258: 242.
Lim, D., Gewurz, A., Lint, T. F., Ghaze, M., Sepheri, B., and Gewurz, H., Absence of the sixth complement in a patient with repeated episodes of meningococcal meningitis, J. Pediatr., in press.
Mauff, G., Hummel, K., and Pulverer, G., 1975, Properdin Factor B (glycine-rich beta-glycoprotein or C3 proactivator)-polymorphism: genetic and biochemical aspects. First application to paternity cases, Z. Immunitaetsforsch. Exp. Ther. 150: 327.
Olaisen, B., Teisberg, P., Gedde-Dahl, T., Jr., and Thorsby, E., 1975, The Bf locus in the HLA region of chromosome 6: linkage and association studies. Humangenetik 30: 291.
Osofsky, S. G., Thompson, B. H., Lint, T. F., and Gewurz. H., Hereditary deficiency of the third component of complement in a child with fever, skin rash and arthralgias, and response to whole blood transfusion, submitted for publication.
Petersen, B. H., Graham, J. A., and Brooks, G. F., 1975, Human deficiency of the 8th component of complement: lack of bactericidal activity, Clin. Res. 23: 295A.
Raum, D., Schur, P. H., Hobart, M. J., and Alper, C. A., Unpublished observations.
Raum, D., Glass, D., Carpenter, C. B., Alper, C. A., and Schur, P. H., 1976, Linkage of Factor B, C2 deficiency, and HLA, and ordering of genes on chromosome six (Abstract), Clin. Res. 24: 335A.
Thompson, R. A., 1976, Proc. Br. Soc. Inzmunol., spring meeting, p. 33.
Jasin, H. E., Personal communication.
Rosenfeld, S. I., Kelly, M. E., and Leddy, J. P., 1976, Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies, J. Clin. Invest. 57: 1626.
Rosenfeld, S. I., Baum, J., Steigbigel, R. T., and Leddy, J. P., 1976, Hereditary deficiency of the fifth component of complement in man. II. Biological properties of CS-deficient human serum, J. Clin. Invest. 57: 1635.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Springer Science+Business Media New York
About this chapter
Cite this chapter
Alper, C.A., Rosen, F.S. (1976). Genetics of the Complement System. In: Harris, H., Hirschhorn, K. (eds) Advances in Human Genetics. Advances in Human Genetics, vol 7. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0659-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0659-8_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0661-1
Online ISBN: 978-1-4757-0659-8
eBook Packages: Springer Book Archive